Patent details

EP3041476 Title: CORTICOSTEROID CONTAINING ORALLY DISINTEGRATING TABLET COMPOSITIONS FOR EOSINOPHILIC ESOPHAGITIS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3041476
WO Application Number:
US2014054203
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP14842811.3
WO Publication Number:
WO2015035114
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
05/09/2014
Grant date:
06/11/2019
EP Publication Date:
13/07/2016
WO Publication Date:
12/03/2015
Claims Translations Received Date:
Claims Translation B1 Received Date:
09/01/2020
Claims Translation B2 Received Date:
05/04/2023
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/10/2024
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
06/11/2019
EP B1 Publication Date:
06/11/2019
EP B2 Publication Date:
25/01/2023
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
04/09/2034
Lapsed By Expiration Date:
Patent Validated Date:
22/04/2023
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
09/01/2020
 
 

 

Name:
Adare Pharmaceuticals US, L.P.
Address:
1200 Lenox Drive, Suite 100, 08648, Lawrenceville, NJ, United States of America (US)

Historical Applicant/holder

From:
06/11/2019
To:
09/01/2020

 

Name:
Adare Development I, L.P.
Address:
1200 Lenox Drive, Suite 100, Lawrenceville, NJ 08648, United States of America (US)

Agent

Name:
dr. A. Krebs
From:
09/01/2020
Address:
HGF B.V. Benoordenhoutseweg 46, 2596 BC, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
GOSSELIN, Michael, A.
Address:
Springboro, OH 45066, United States of America (US)

2

Name:
LAI, Jin-Wang
Address:
Springboro, OH 45066, United States of America (US)

3

Name:
VENKATESH, Gopi,M.
Address:
Vandalia, OH 45377, United States of America (US)

Priority

Priority Patent Number:
201361874450 P
Priority Date:
06/09/2013
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 9/20; A61K 31/56; A61P 1/00; A61P 1/04; A61P 29/00; A61K 9/00;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
19/25
Publication date:
07/05/2025
Description:
Lapse or annulment

2

Bulletin Heading:
EP5
Journal edition number:
17/23
Publication date:
26/04/2023
Description:
European patents granted in amended form for the Netherlands in which an amended translation was filed ex Article 52 par. 6 of the NL Patent Law 1995

3

Bulletin Heading:
EP4
Journal edition number:
04/23
Publication date:
25/01/2023
Description:
European patents granted in amended form for the Netherlands

4

Bulletin Heading:
MED
Journal edition number:
04/23
Publication date:
25/01/2023
Description:
Other communications

5

Bulletin Heading:
EP3
Journal edition number:
08/20
Publication date:
19/02/2020
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

6

Bulletin Heading:
CO
Journal edition number:
08/20
Publication date:
19/02/2020
Description:
Changes in the Netherlands Patent Register

7

Bulletin Heading:
EP2
Journal edition number:
45/19
Publication date:
06/11/2019
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202304
Publication date:
25/01/2023
Description:
Patent maintained (B2 publication)

2

Issue number:
202206
Publication date:
09/02/2022
Description:
International Patent Classification Changed

3

Issue number:
201950
Publication date:
11/12/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

4

Issue number:
201945
Publication date:
06/11/2019
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC202000318A
Date Registered:
09/01/2020
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. A. Krebs
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Adare Pharmaceuticals US, L.P.
Address:
1200 Lenox Drive, Suite 100, 08648, Lawrenceville, NJ, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
26/09/2023
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
400 Euro
Payer:
Computer Packages Inc. (CPI)
Filing date Document type Document Description Number of pages File Type
21/04/2023 Outgoing Correspondence Letter no formal defects 1 PDF /3/9/5/9/7/0800479593/docs/ep14842811.3_2_542528l271.pdf
05/04/2023 Claims First filed claims 6 PDF /3/9/5/9/7/0800479593/docs/ep14842811.3_3_claims20230405164511460.pdf
13/02/2020 Outgoing Correspondence Letter no formal defects 1 PDF /3/9/5/9/7/0800479593/docs/ep14842811.3_1_325778l271.pdf
09/01/2020 Claims First filed claims 7 PDF /3/9/5/9/7/0800479593/docs/ep14842811.3_0_claims20200109124554183.pdf